Biocryst Pharmaceuticals Inc (BCRX)
CapEx to Revenue
0.10%
Quarterly · Period ending:
BCRX CapEx to Revenue
Latest reported0.10%period ending
Latest reported0.10%period ending
BCRX Quarterly CapEx/Revenue (100.00% → 0.10%)
Latest values, visible window
High-resolution chart · PNG
BCRX capex to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 0.0958% | |
| 0.2577% | |
| 0.1973% | |
| 0.8432% | |
| 0.1096% | |
| 0.0983% | |
| 0.5132% | |
| 0.0504% | |
| 0.1418% | |
| 0.2533% | |
| 0.5931% | |
| 1.1379% | |
| 0.5661% | |
| 0.2326% | |
| 0.6613% | |
| 0.2308% | |
| 0.3723% | |
| 0.8133% | |
| 2.3495% | |
| 0.8904% | |
| 1.6273% | |
| 0.5194% | |
| 3.8596% | |
| 2.8187% | |
| 2.473% | |
| 2.4051% | |
| 0.2014% | |
| 4.6761% | |
| 6.0083% | |
| 1.5798% | |
| 3.8109% | |
| 2.8198% | |
| 1.4887% | |
| 0.8803% | |
| 2.9563% | |
| 2.1575% | |
| 0.6776% | |
| 0.0318% | |
| 58.7554% | |
| 2.3058% | |
| 38.4165% | |
| 67.6349% | |
| 87.9183% | |
| 1.2924% | |
| 1.4279% | |
| 8.2772% | |
| 1.1935% | |
| 1.05% | |
| 0% | |
| 0.2024% | |
| 0.0379% | |
| 0% | |
| 3.1669% | |
| 0% | |
| 2.8042% | |
| 0.1041% | |
| 0.9501% | |
| 0.5646% | |
| 0.0191% | |
| 0.0191% | |
| 0.6158% | |
| 0.552% | |
| 0.0765% | |
| 0.5417% | |
| 2.1534% | |
| 0.3184% | |
| 0.1689% | |
| 1.3273% | |
| 5.7656% | |
| 2.1794% | |
| 0.2111% | |
| 5.0146% | |
| 19.9323% | |
| 1.523% | |
| 6.5668% | |
| 5.918% | |
| 2.6927% | |
| 3.0243% | |
| 28.571% | |
| 10.5587% | |
| 10.0128% | |
| 76.7834% | |
| 1,525.2983% | |
| 315.625% | |
| 63.7931% | |
| 100% | |
| -33.1982% | |
| 8.8889% | |
| 8.7558% | |
| 67.9558% | |
| 2.2673% | |
| 2.7027% | |
| 1.5038% | |
| 7.4675% | |
| 112.8201% | |
| 0.2427% | |
| 36.6594% | |
| 44.5269% | |
| 22.6677% | |
| 32.0882% |